Jubilant Pharmova Limited (NSE:JUBLPHARMA)

Jubilant Pharmova Revenue

Jubilant Pharmova had revenue of 22.49B INR in the quarter ending June 30, 2026, with 18.34% growth. This brings the company's revenue in the last twelve months to 86.16B, up 16.38% year-over-year. In the fiscal year ending March 31, 2026, Jubilant Pharmova had annual revenue of 82.80B with 14.45% growth.

• Revenue (ttm): 86.16B
• Revenue Growth: +16.38%
• P/S Ratio: 1.77
• Revenue / Employee: 15.23M
• Employees: 5,547
• Market Cap: 152.48B

Revenue Chart

Chart

Chart

Revenue History

Fiscal Year End	Revenue	Change	Growth
Mar 31, 2026	82.80B	10.45B	14.45%
Mar 31, 2025	72.35B	5.32B	7.93%
Mar 31, 2024	67.03B	4.21B	6.71%
Mar 31, 2023	62.82B	1.52B	2.47%
Mar 31, 2022	61.30B	316.29M	0.52%

Data Source: S&P Global Market Intelligence Last updated: Jun 30, 2026

Revenue data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Aug 11, 2026

Data Sources Report a data error